Neuphoria Therapeutics Inc. (NEUP) — Institutional Holders, Q2 2026
22 institutional investment managers reported a NEUP position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $8.7M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
NEUP in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- VANGUARD CAPITAL MANAGEMENTNew · +173,488 sh+$758.1K
- AdvisorShares InvestmentsAdded · +97,542 sh+$426.3K
- CITADEL ADVISORSAdded · +53,228 sh+$232.6K
- VANGUARD FIDUCIARYNew · +33,806 sh+$147.7K
- RENAISSANCE TECHNOLOGIESNew · +25,500 sh+$111.4K
Biggest sellers
- Squadron Capital ManagementSold out · -76,728 sh-$335.3K
- Virtu FinancialSold out · -12,033 sh-$52.6K
- GEODE CAPITAL MANAGEMENTTrimmed · -2,491 sh-$10.9K
- RHUMBLINE ADVISERSSold out · -202 sh-$883.00
- UBS Group AGTrimmed · -199 sh-$870.00
NEUP 13F holders ranked 1–22 of 22
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Lynx1 Capital Management#1 · 875,328 sh | 875,328 | $3.8M | 0.75% | 0.0% |
| 2 | AdvisorShares Investments#2 · 252,909 sh | 252,909 | $1.1M | 0.13% | +62.8% |
| 3 | VANGUARD CAPITAL MANAGEMENT#3 · 173,488 sh | 173,488 | $758.1K | 0.00% | New |
| 4 | Shay Capital#4 · 155,822 sh | 155,822 | $680.9K | 0.04% | +3.2% |
| 5 | BALYASNY ASSET MANAGEMENT L.P.#5 · 142,228 sh | 142,228 | $621.5K | <0.01% | 0.0% |
| 6 | CITADEL ADVISORS#6 · 72,559 sh | 72,559 | $317.1K | 0.00% | +275.4% |
| 7 | GEODE CAPITAL MANAGEMENT#7 · 49,516 sh | 49,516 | $216.4K | 0.00% | -4.8% |
| 8 | Ikarian Capital#8 · 47,443 sh | 47,443 | $207.3K | 0.02% | 0.0% |
| 9 | VANGUARD FIDUCIARY#9 · 33,806 sh | 33,806 | $147.7K | 0.00% | New |
| 10 | ADAR1 Capital Management#10 · 30,000 sh | 30,000 | $131.1K | <0.01% | 0.0% |
| 11 | FNY Investment Advisers#11 · 26,500 sh | 26,500 | $115.0K | — | 0.0% |
| 12 | RENAISSANCE TECHNOLOGIES#12 · 25,500 sh | 25,500 | $111.4K | <0.01% | New |
| 13 | XTX Topco Ltd#13 · 23,089 sh | 23,089 | $100.9K | <0.01% | New |
| 14 | HRT FINANCIAL#14 · 22,865 sh | 22,865 | $99.0K | <0.01% | New |
| 15 | JANE STREET GROUP#15 · 14,903 sh | 14,903 | $65.1K | 0.00% | New |
| 16 | BOOTHBAY FUND MANAGEMENT#16 · 14,000 sh | 14,000 | $61.2K | <0.01% | 0.0% |
| 17 | COMMONWEALTH EQUITY SERVICES#17 · 11,222 sh | 11,222 | $49.0K | <0.01% | 0.0% |
| 18 | NORTHERN#18 · 10,610 sh | 10,610 | $46.4K | 0.00% | New |
| 19 | Merck#19 · 10,027 sh | 10,027 | $43.8K | <0.01% | 0.0% |
| 20 | UBS Group AG#20 · 2,117 sh | 2,117 | $9.3K | 0.00% | -8.6% |
| 21 | MORGAN STANLEY#21 · 58 sh | 58 | $254.00 | 0.00% | 0.0% |
| 22 | Caitong International Asset Management , Ltd#22 · 3 sh | 3 | $13.00 | 0.00% | New |
Funds that sold out of NEUP in Q2 2026 (3)
Held NEUP at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Squadron Capital Management76,728 sh | 76,728 | $312.3K |
| Virtu Financial12,033 sh | 12,033 | $49.0K |
| RHUMBLINE ADVISERS202 sh | 202 | $822.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.